OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic medication for women with schizophrenia spectrum disorders
Bodyl A. Brand, Yudith R. A. Haveman, Franciska de Beer, et al.
Psychological Medicine (2021) Vol. 52, Iss. 4, pp. 649-663
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Male sex bias in early and late onset neurodevelopmental disorders: Shared aspects and differences in Autism Spectrum Disorder, Attention Deficit/hyperactivity Disorder, and Schizophrenia
Sofia Santos, Helena Ferreira, João Martins, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 135, pp. 104577-104577
Open Access | Times Cited: 97

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
Iris E. Sommer, Bodyl A. Brand, Shiral S. Gangadin, et al.
Schizophrenia Bulletin (2022) Vol. 49, Iss. 1, pp. 136-143
Open Access | Times Cited: 39

Potential Differences in Psychedelic Actions Based on Biological Sex
Sheida Shadani, Kyna‐Anne Conn, Zane B. Andrews, et al.
Endocrinology (2024) Vol. 165, Iss. 8
Open Access | Times Cited: 9

Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database
Takumi Ebina, Kunihiro Iwamoto, Masahiko Ando, et al.
Psychiatry and Clinical Neurosciences (2025)
Open Access | Times Cited: 1

Towards better care for women with schizophrenia-spectrum disorders
Bodyl A. Brand, Janna N. de Boer, Paola Dazzan, et al.
The Lancet Psychiatry (2022) Vol. 9, Iss. 4, pp. 330-336
Open Access | Times Cited: 35

Voice Patterns as Markers of Schizophrenia: Building a Cumulative Generalizable Approach Via a Cross-Linguistic and Meta-analysis Based Investigation
Alberto Parola, Arndis Simonsen, Jessica Mary Lin, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. Supplement_2, pp. S125-S141
Open Access | Times Cited: 18

The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia
Agnieszka Matuszewska, Krzysztof Kowalski, Paulina Jawień, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6492-6492
Open Access | Times Cited: 17

Sex and mental health are related to subcortical brain microstructure
Diliana Pecheva, Diana M. Smith, B.J. Casey, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 31
Closed Access | Times Cited: 7

Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals
Kristine Tveit, Monica Hermann, Roy M. Nilsen, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 3, pp. 435-444
Open Access | Times Cited: 5

Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders
Bodyl A. Brand, Elske J. M. Willemse, Iris M. H. Hamers, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 723-733
Open Access | Times Cited: 12

Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review
Danae Papadea, Christina Dalla, Despina Α. Tata
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 461-461
Open Access | Times Cited: 11

Sex differences need to be considered when treating women with psychotropic drugs
Iris E. Sommer, Bodyl A. Brand, Clementine C. M. Stuijt, et al.
World Psychiatry (2024) Vol. 23, Iss. 1, pp. 151-152
Open Access | Times Cited: 4

Long-acting antipsychotic treatments: focus on women with schizophrenia
Sofia Brissos, Vicent Balanzá‐Martínez
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 4

The influence of female sex and estrogens on drug pharmacokinetics: what is the evidence?
Ernesto Bosch, Iris E. Sommer, Daan J. Touw
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-11
Open Access

Schizophrenia in women: a review of unique aspects regarding course, management, and challenges across the lifespan
Marcela Almeida, Sun J. Fletcher, Melisa D. Granoff
Current Opinion in Psychiatry (2025) Vol. 38, Iss. 3, pp. 169-176
Closed Access

Sex and age effects on prevalence of CYP2C19 and CYP2D6 Phenoconversion risk over time in patients with psychosis
Emma Y De Brabander, Nicole Leibold, Thérèse van Amelsvoort, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111363-111363
Closed Access

Community Therapeutic Space for Women with Schizophrenia: A New Innovative Approach for Health and Social Recovery
M. Natividad, Marcelo Chavez, Ariadna Balagué, et al.
Women (2025) Vol. 5, Iss. 2, pp. 13-13
Open Access

Unveiling the Neurotransmitter Symphony: Dynamic Shifts in Neurotransmitter Levels during Menstruation
Mayur B. Kale, Nitu L. Wankhede, Barkha K. Goyanka, et al.
Reproductive Sciences (2024) Vol. 32, Iss. 1, pp. 26-40
Closed Access | Times Cited: 3

Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
I. Ratke, A. Torsvik, C.A. Bartz-Johannessen, et al.
Brain Behavior & Immunity - Health (2025) Vol. 44, pp. 100959-100959
Open Access

The Effect of Age on Antipsychotic Serum Concentration in Males and Females: A Study Based on Therapeutic Drug Monitoring Data From 19,926 Patients
Vigdis Solhaug, Ragnhild Birkeland Waade, Espen Molden, et al.
Therapeutic Drug Monitoring (2025)
Closed Access

INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia
Robert A. McCutcheon, Toby Pillinger, Ioana Varvari, et al.
The Lancet Psychiatry (2025)
Closed Access

Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies
Bram W C Storosum, Taina Mattila, Tamar Wohlfarth, et al.
Psychiatry Research (2022) Vol. 320, pp. 114997-114997
Open Access | Times Cited: 16

Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition
Bodyl A. Brand, Janna N. de Boer, Elske J. M. Willemse, et al.
Archives of Women s Mental Health (2024) Vol. 27, Iss. 6, pp. 931-941
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top